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Introduction
This poster aims to discuss the
pathophysiology of the two main mood
disorders: major depressive disorder and
bipolar disorder. The exact etiology of
these two disorders remains not fully
understood, but it is known that the
pathophysiology is complex and
multifaceted. This poster discusses
theories concerning neuroinflammation
and their contribution to the
pathophysiology of mood disorders. The
role of neuroinflammation in mood
disorders is a relatively recent area of
research that has shown promising
results making it worthy of continued
attention. By continuing to progress
research in this area new and effective
treatment can be developed to help
individuals all over the world who do not
achieve remission with traditional
treatments or who continue to have
residual lifelong symptoms even after
remission.

Monoamine hypothesis of
depression: the
traditional theory of
mood disorder
pathophysiology which
states an imbalance in
neurotransmitters is the
cause of depression or
mania.

Some recent theories
investigate the role of
inflammation
Inflammation is an innate protective
response in the body that activates when
an injury or threat is detected. Cellular
signals release chemicals, or cytokines,
that work synergistically to eradicate
infection and repair tissue (Rainville &
Hodes, 2019). Chronic inflammation
results when the initial response is
ineffective at achieving homeostasis
within the body or if the assault to the
body is prolonged (Dey & Hankey Giblin,
2018; Rainville & Hodes, 2019). Chronic
inflammation leads to pathosis. (Dey &
Hankey Giblin, 2018; Rainville & Hodes,
2019)

Role of
inflammation in
pathophysiology of
mood disorders
Normal brain function relies on low
levels of inflammatory cytokines
(McCance & Huether, 2019).
Patients with mood disorders have been
found to be in a state of chronic proinflammatory production causing
elevated numbers (Dey & Hankey Giblin,
2018)

Depression: low concentration
of norepinephrine, dopamine,
and/or serotonin
•
Mania: high concentration of
monoamines such as dopamine,
norepinephrine, serotonin,
and/or gamma-aminobutyrate
•
Antidepressant medications
balance the levels of these
neurotransmitters in the brain
by preventing their reuptake
and thus increasing the amount
available to receptors
(Ashok et al., 2017; McCance &
Huether, 2019;)
•

post-synaptic
nerve ending

t

Receptor sites

(Cottone, 2020)

Major Mood Disorder Symptomology

Elevated proinflammatory cytokines
contribute to:
•
Neural atrophy
•
Decreased synaptogenesis
•
Compromised blood-brain barrier
•
Diversion of tryptophan metabolism
from serotonin towards excitotoxic
chemicals
•
Chronic cortisol release and
hippocampal damage
•
Increase in reactive oxidative species
These elements have all been found to play
a role in the development of mood
disorders (McCance & Huether, 2019;
Offor et al., 2021; Rakofsky & Rapaport,
2018)
Most common proinflammatory cytokines
found in patients with mood disorders
include IL-1α, IL-β, IL-6, tumor necrosis
factor (TNF-α), and C-reactive protein (Dey
& Hankey Giblin, 2018; Gourgouvelis et al.,
2018; McCance & Huether, 2019;
Mikkelsen et al., 2017)

Major depressive disorder
Loss of interest or pleasure in activities
Sleep and eating pattern changes
Irritable or down mood
Fatigue, difficulty concentrating
Suicidal ideation

•
•
•
•
•

Bipolar
Bipolar 1 – Manic episode usually followed by hypomanic or a major depressive
episode
•
Bipolar 2 – Major depressive episode for at least two weeks and a hypomanic
episode for 4 days
•
Manic episode
•
Elevated or irritable mood
•
Increased energy and decreased need for sleep
•
Pressured speech and racing thoughts
•
Distractibility
•
Excessive risk taking
•
Inflated self-confidence
(McCance & Huether, 2019)
•

(Offor et al., 2021)

Mood disorder treatments addressing the
role of inflammation

High levels of IL-6 are associated with
suicidality (Mikkelsen et al., 2017).
Most common anti-inflammatory cytokines
found in decreased levels include IL-1
receptor antagonist and IL-10
(Gourgouvelis et al., 2018).

Poor diet and a sedentary lifestyle have been shown to exacerbate mood disorders
and contribute to low-grade chronic inflammation (Gourgouvelis et al., 2018 & Offor
et al., 2021). Poor diet also effects production and function of neurotransmitters
making someone more susceptible to developing a psychiatric condition (Mikkelsen et
al., 2017).

A healthy diet and regular exercise have been shown to alleviate
mood disorder symptoms (Gourgouvelis et al., 2018; Mikkelsen et
al., 2017; Offor et al., 2021)
Antidepressants
have been found to
also work by
decreasing the
production of proinflammatory
cytokines and
reversing neural
atrophy (Dey &
Hankey Giblin, 2018;
McCance & Huether,
2019; Rakofsky &
Rapaport, 2018)

Effects of dietary interventions on bio-markers of mental conditions

•
•
•

•
•

Several dietary interventions have been shown to decrease systemic
inflammation as depicted in the above right illustration (Offor et al., 2021)
Exercise inhibits pro-inflammatory cytokine release and increases antiinflammatory cytokines production (Mikkelsen et al., 2017)
Large adipocytes increase proinflammatory cytokine release. Regular exercise
decreases adipose tissue, and therefore reduces systemic inflammation
(Mikkelsen et al., 2017)
The vagus nerve regulates inflammation. Exercise strengthens vagal tone
reducing systemic inflammation (Mikkelsen et al., 2017)
Exercise interventions have been shown to be as effective as pharmacological and
cognitive behavioral therapy treatments (Gourgouvelis et al., 2018)
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Conclusion
The benefits of a healthy diet and
regular physical activity are more
pronounced for individuals with
mood disorders (Kruisdijk et al.,
2018). With the role that
neuroinflammation plays in the
pathophysiology of mood
disorders, new treatments that
reduce proinflammatory cytokines
and reverse their negative effects
on the brain could be essential to
the future of psychiatric
treatment. However,
neuroinflammation is only one
factor in a complex interaction
between genetics, anatomy,
physiology, and environment that
together either protect against or
make one at risk for a mood
disorder. Research must continue
to progress in the investigation of
mood disorder pathophysiology in
order to develop diversity in
treatment options. The possibility
of treatment choice will lead to
increased remission rates,
decreased relapse rates, and
individuals with mood disorders
who are able to function more
independently and successfully
within their families, their
communities, and society
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